Tested, Trialled and Dusted some 40 years ago. The general conclusion was: "We conclude that triciribine is ineffective at all doses tested and at doses of ≥35 mg/m2 has unacceptable toxic effects." [Hoffman et al. Cancer Chemotherapy and Pharmacology, 1996, 37:3, pp 254-258. Buyer Beware.
http://www.ncbi.nlm.nih.gov/pubmed/...he Cervix: A Gynecologic Oncology Group Study
http://www.ncbi.nlm.nih.gov/pubmed/...cancer. Cancer Treat Rep 71(3): 333-334, 1987
http://www.ncbi.nlm.nih.gov/pubmed/8256767
http://www.ncbi.nlm.nih.gov/pubmed/...oside phosphate) for metastatic breast cancer
http://www.ncbi.nlm.nih.gov/pubmed/...using a five-day continuous infusion schedule
http://www.ncbi.nlm.nih.gov/pubmed/6825123
- Forums
- ASX - By Stock
- VHL
- Previous trials with TCN-P
VHL
vitasora health limited
Add to My Watchlist
6.90%
!
2.7¢

Previous trials with TCN-P
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $46.40M |
Open | High | Low | Value | Volume |
2.9¢ | 3.0¢ | 2.6¢ | $22.40K | 784.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12646 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 523829 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12646 | 0.027 |
2 | 131038 | 0.026 |
1 | 20000 | 0.025 |
2 | 245000 | 0.024 |
3 | 210485 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 523829 | 3 |
0.031 | 360000 | 2 |
0.032 | 1000000 | 2 |
0.033 | 67000 | 2 |
0.034 | 687500 | 3 |
Last trade - 15.59pm 10/09/2025 (20 minute delay) ? |
Featured News
VHL (ASX) Chart |
The Watchlist
EVR
EV RESOURCES LTD
Shane Menere, Non-Executive Chairman
Shane Menere
Non-Executive Chairman
SPONSORED BY The Market Online